Last reviewed · How we verify
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases (BCG-LT)
Rationale: The effects of BCG vaccination have been only sporadically studied in the elderly, and the long-term effects of the vaccination have not been studied until now. There is evidence that BCG vaccination beneficially influences susceptibility and severity of infectious and inflammatory diseases; however, the specifics, extent and duration of these effects are not known yet. With this observational study we would like to determine the extent of these effects in the elderly. Objective: To identify any long term effects of BCG vaccination on the incidence of infectious and inflammatory diseases may have in the elderly Study design: Cohort study with a duration of 5 years Study population: Older adults who participated in two large randomized BCG vaccination trials in 2020/2021 (BCG-CORONA-OUDEREN, BCG-PRIME), who have consented to be contacted for further studies Main study parameters/endpoints: The incidence of infectious and inflammatory diseases in the placebo- vs. BCG-vaccinated individuals
Details
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 4292 |
| Start date | Fri May 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Jun 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- BCG Vaccination Reaction
- Infections
- Inflammation
- COVID-19
Interventions
- BCG
- Placebo vaccine
Countries
Netherlands